Dihydropyridine calcium antagonists: the role in current therapy of cardio-vascular diseases

被引：0
|
作者：
Shilova, E. V. [1 ]
Martsevich, S. Y. [1 ]
机构：
[1] State Res Ctr prevent Med Rosmedtechnol, Moscow, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2008年 / 4卷 / 02期
关键词：
calcium antagonists; dihydropiridines; arterial hypertension; ischemic heart disease; cardiovascular risk; amlodipine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Classification of calcium antagonists (CA) is presented. Results of the large clinical trials (STONE, STOP-Hypertension-2, ALLHAT, ASCOT-BPLA etc.) devoted to estimation of CA effects on the risk of cardiovascular complications are analyzed. The significant place of dihydropyridine CA in current guidelines on arterial hypertension and ischemic heart disease therapy is underlined. Results of a pilot study on comparison of two amlodipines (original Norvasc and generic Stamlo M) are discussed.
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
12345